Literature DB >> 2408473

The relationship between perinatal hypoxia and newborn encephalopathy.

J A Low, R S Galbraith, D W Muir, H L Killen, E A Pater, E J Karchmar.   

Abstract

Newborn encephalopathy was observed in 30% of 303 selected high-risk preterm and term newborn infants. The newborn encephalopathy was mild or moderate in 65 children and severe in 27. The predictive significance of newborn encephalopathy to motor and cognitive deficits at 1 year was evident from the incidence of deficits in the children with no encephalopathy (17%), in children with mild or moderate encephalopathy (25%), and in children with severe encephalopathy (55%). The biologic risk factors with a significant association with newborn encephalopathy included severe intrapartum fetal hypoxia, moderate and severe newborn respiratory complications, and major infections. Perinatal hypoxia was associated with, and may have contributed to, 26% of the cases of mild and moderate newborn encephalopathy and 66% of the cases of severe newborn encephalopathy. Fetal and newborn hypoxia occurred with equal frequencies in cases of mild and moderate encephalopathy; however, newborn hypoxia was twice as frequent as fetal hypoxia in cases of severe newborn encephalopathy.

Entities:  

Mesh:

Year:  1985        PMID: 2408473     DOI: 10.1016/s0002-9378(85)80205-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Risk factors for neonatal encephalopathy in Kathmandu, Nepal, a developing country: unmatched case-control study.

Authors:  M Ellis; N Manandhar; D S Manandhar; A M Costello
Journal:  BMJ       Date:  2000-05-06

2.  Calcitonin gene-related peptide contributes to the umbilical haemodynamic defence response to acute hypoxaemia.

Authors:  A S Thakor; D A Giussani
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

3.  Post-hypoxic changes in rat cortical neuron GABA A receptor function require L-type voltage-gated calcium channel activation.

Authors:  Liping Wang; L John Greenfield
Journal:  Neuropharmacology       Date:  2008-07-12       Impact factor: 5.250

4.  Fetal brain sparing in a mouse model of chronic maternal hypoxia.

Authors:  Lindsay S Cahill; Johnathan Hoggarth; Jason P Lerch; Mike Seed; Christopher K Macgowan; John G Sled
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-22       Impact factor: 6.200

5.  Perinatal acidosis and hypoxic-ischemic encephalopathy in preterm infants of 33 to 35 weeks' gestation.

Authors:  Lina F Chalak; Nancy Rollins; Michael C Morriss; Luc P Brion; Roy Heyne; Pablo J Sánchez
Journal:  J Pediatr       Date:  2011-10-26       Impact factor: 4.406

6.  Calcitonin gene-related peptide antagonism attenuates the haemodynamic and glycaemic responses to acute hypoxaemia in the late gestation sheep fetus.

Authors:  A S Thakor; M R Bloomfield; M Patterson; D A Giussani
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

7.  Striatal GABA receptor alterations in hypoxic neonatal rats: role of glucose, oxygen and epinephrine treatment.

Authors:  T R Anju; J Binoy; M Anitha; C S Paulose
Journal:  Neurochem Res       Date:  2011-11-17       Impact factor: 3.996

8.  The value of entry criteria in follow-up clinics for neonatal intensive care unit graduates.

Authors:  R S Galbraith; E Derrick
Journal:  Paediatr Child Health       Date:  1998-05       Impact factor: 2.253

9.  Quantitative susceptibility mapping in the human fetus to measure blood oxygenation in the superior sagittal sinus.

Authors:  Brijesh Kumar Yadav; Sagar Buch; Uday Krishnamurthy; Pavan Jella; Edgar Hernandez-Andrade; Anabela Trifan; Lami Yeo; Sonia S Hassan; E Mark Haacke; Roberto Romero; Jaladhar Neelavalli
Journal:  Eur Radiol       Date:  2018-10-01       Impact factor: 5.315

10.  Clinical evaluation of the fetus and neonate. Relation between intra-partum cardiotocography, Apgar score, cord blood acid-base status and neonatal morbidity.

Authors:  L Valentin; G Ekman; P E Isberg; S Polberger; K Marsál
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.